A joint research report from the International Association of Patients’ Organisations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Download Full Report
TORONTO, Oct. 4, 2016 /CNW/ – In light of upcoming policy decisions that may force patients on certain medications to switch to lower-cost alternatives, Crohn’s and Colitis.
TORONTO, Oct. 3, 2016 /CNW/ – Heath Canada has just approved Canada’s sixth biosimilar and suggests we may have up to 60 more biosimilars applications over the next two.
Join us for a dialogue with pCPA (panCanadian Pharmaceutical Alliance) Many thanks to all who completed our online survey. Now is your chance to interact with pCPA.